Live Biotechnology (Shenzhen) Co., Ltd

Liver-Biotech, established in 2016, is a national high-tech enterprise integrating R&D, production and sales. It is based in Shenzhen, one of the capitals of science and technology in China, and is located in the Life-Science Industrial Park of International Bio Valley in Dapeng New District. Our company possesses biosafety secondary laboratory, primary hepatocyte bank, GMP factory, which are in total of 1,500 square meters, and  the high-end equipment of more than 20 million yuan.

            Liver-Biotech has not only successively obtained the qualifications of National High-tech Enterprise (2021), Biosafety Level 2 Laboratory (2021), ISO9001 Quality Management System (2021-2026), GB/T 29490-2013 Intellectual Property Standard Implementation (2021-2026) and other qualifications, but also was authorized  3 invention patents, 14 utility models, and 3 software copyrights. The breakthrough and transformation application of primary hepatocytes has received three government grants.

The company's primary hepatocyte series covers the hepatocytes of humans, monkeys, dogs, pigs, rabbits, mice, fish, agricultural economical animals, and other species, forming the most complete primary hepatocyte bank in China.

            The company’s technical service uses 2D hepatocyte culture, co-culture of hepatocyte and liver nonparenchymal cells, liver-on-chip, and other models, to provide professional CRO services such as evaluation of drug efficacy and drug toxicology for institutes and biotech enterprises.

The company's advantageous products also contain organoid series, immune cell series, and cell culture reagent consumables series. Organoid series, including general-use ECM gel, organ-specific ECM gel, ultra-low attachment culture consumables, etc. It has unique performance in applications such as organoid maturation and stem cell differentiation, 3D printing, and PDX models.

            Behind all of this, there is a team of skilled talents. Dr. Zhou Ming, the founder of Liver-Biotech, is a high-level talent in Shenzhen, and the R&D team is composed of academicians, professors and doctors. The R&D personnel account for more than 50%, of which R&D personnel with master's degrees account for more than 60%.

     With the world's characteristic primary hepatocyte bank as the engine, Liver-Biotech provides professional, accurate, systematic and all-around solutions, covering scientific research, drug evaluation, the medical industry and others. Liver-Biotech adheres to quality and innovation, actively promotes the industrialization and transformation of primary cells, organoids, organ-on-chips, and artificial organs, moves towards higher and stronger Chinese creation, and casts the brand of Liver Biotech.